Your browser doesn't support javascript.
loading
Part 2: Making the "unproven" "proven".
Weiss, Daniel J; Rasko, John E J; Cuende, Natividad; Ruiz, Milton A; Ho, Hong-Nerng; Nordon, Robert; Wilton, Steve; Dominici, Massimo; Srivastava, Alok.
Afiliación
  • Weiss DJ; Department of Medicine, University of Vermont, Burlington, Vermont, USA. ISCT Chief Scientific Officer 2014-2016. Chair, ISCT Pulmonary Committee 2013-2015. Electronic address: dweiss@uvm.edu.
  • Rasko JE; Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital, Centenary Institute, Sydney Medical School, University of Sydney, Sydney, Australia. ISCT Australia & New Zealand, Past Regional Vice President 2008-2012.
  • Cuende N; Andalusian Initiative for Advanced Therapies, Junta de Andalucía, Sevilla, Spain. Chair, ISCT EU LRA Committee, 2014-2016.
  • Ruiz MA; Bone Marrow Transplantation and Cell Therapy Unit, Associação Portuguesa de Beneficencia, SJ Rio Preto, Sao Paulo, Brazil. ISCT South & Central America, Past Regional Vice President 2013-2015.
  • Ho HN; Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, Taiwan. ISCT Asia, Past Regional Vice President 2013-2015.
  • Nordon R; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia. ISCT Australia & New Zealand, Regional Vice-President 2014-2016.
  • Wilton S; Western Australian Neuroscience Research Institute, Centre for Comparative Genomics, Murdoch University, Perth, Australia. Member at large of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
  • Dominici M; Division of Oncology, Laboratory of Cellular Therapy, University of Modena & Reggio Emilia, Modena, Italy. ISCT President 2014-2016. Chair of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
  • Srivastava A; Center for Stem Cell Research (a unit of inStem, Bengaluru), Department of Hematology, Christian Medical College, Vellore, India. Member at large of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
Cytotherapy ; 18(1): 120-3, 2016 Jan.
Article en En | MEDLINE | ID: mdl-26719203
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article